Filing Flows

Filing Flows › Companies › Bristol Myers Squibb › Timeline

Bristol Myers Squibb stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+39.1% to $62.14

Bristol Myers Squibb (BMY) stock rose 39% over the last 252 sessions, to $62.14. On the way it reported 4 quarters, its insiders filed 2 open-market trades and 3 Form 144 notices of planned sales, and the company filed 0 material 8-Ks. Each is marked on the price and listed with what the stock did next.

BMY: a year of the stock with every disclosure on itBMY: a year of the stock with every disclosure on it$48.80$55.63$62.45$69.27●2026-02-05 · Earnings: beat the EPS estimate by 4.6%●2026-04-30 · Earnings: beat the EPS estimate by 11.2%●2026-07-30 · Earnings: beat the EPS estimate by 27.7%▼2026-08-25 · Holzer Phil M sold $34K▽2026-08-25 · Form 144: Phil M Holzer plans to sell $34K▼2026-09-09 · Massacesi Cristian sold $403K▽2026-09-09 · Form 144: Cristian Massacesi plans to sell $403K●2026-10-29 · Earnings: beat the EPS estimate by 15.2%▽2026-11-05 · Form 144: Julia A Haller Gottsch plans to sell $250K●Earnings report▼Insider sale▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 5, 2026Form 144Form 144: Julia A Haller Gottsch plans to sell $250K−1.7% (+2.8% vs SPY)——
Oct 29, 2026EarningsEarnings: beat the EPS estimate by 15.2%+1.3% (+1.7% vs SPY)+5.8% (+6.5% vs SPY)—
Sep 9, 2026Form 144Form 144: Cristian Massacesi plans to sell $403K−0.4% (0.0% vs SPY)−1.5% (−0.4% vs SPY)−7.0% (−8.7% vs SPY)
Sep 9, 2026Insider saleMassacesi Cristian sold $403K−0.4% (0.0% vs SPY)−1.5% (−0.4% vs SPY)−7.0% (−8.7% vs SPY)
Aug 25, 2026Form 144Form 144: Phil M Holzer plans to sell $34K+1.0% (+0.6% vs SPY)−0.7% (−1.2% vs SPY)−9.5% (−10.3% vs SPY)
Aug 25, 2026Insider saleHolzer Phil M sold $34K+1.0% (+0.6% vs SPY)−0.7% (−1.2% vs SPY)−9.5% (−10.3% vs SPY)
Jul 30, 2026EarningsEarnings: beat the EPS estimate by 27.7%+2.7% (+1.1% vs SPY)+0.8% (−4.6% vs SPY)+5.9% (+0.3% vs SPY)
Apr 30, 2026EarningsEarnings: beat the EPS estimate by 11.2%+5.1% (+4.1% vs SPY)−1.7% (−4.8% vs SPY)−0.7% (−6.8% vs SPY)
Feb 5, 2026EarningsEarnings: beat the EPS estimate by 4.6%+3.2% (+4.5% vs SPY)+3.9% (+3.1% vs SPY)+4.6% (+6.6% vs SPY)

Insiders’ record here

In the year on the chart, Bristol Myers Squibb's insiders reported 0 open-market buys ($0) and 2 sales ($437K).

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

Report card: every quarter against the estimate → Bristol Myers Squibb: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.